4//SEC Filing
Glezer Stanislav 4
Accession 0001209191-23-057302
CIK 0001294133other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:29 PM ET
Size
11.4 KB
Accession
0001209191-23-057302
Insider Transaction Report
Form 4
Inogen IncINGN
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-12-01−769→ 5,380 total→ Common Stock (769 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-12-01−3,786→ 3,787 total→ Common Stock (3,786 underlying) - Exercise/Conversion
Common Stock
2023-12-01+4,555→ 12,146 total - Tax Payment
Common Stock
2023-12-01$5.72/sh−2,331$13,333→ 9,815 total
Footnotes (4)
- [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2023.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F3]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
- [F4]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.
Documents
Issuer
Inogen Inc
CIK 0001294133
Entity typeother
Related Parties
1- filerCIK 0001866861
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 6:29 PM ET
- Size
- 11.4 KB